Innocan Pharma Reports Second Quarter 2024 Results with Revenue Growth of over 2.8X to $8.6 Million ...Middle East

PR Newswire - News
Innocan Pharma Reports Second Quarter 2024 Results with Revenue Growth of over 2.8X to $8.6 Million
Innocan Pharma Reports Half Year 2024 Results with Revenue Growth of over 3.3X to $15.4 Million HERZLIYA, Israel and CALGARY, AB, Aug. 12, 2024 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company...

Hence then, the article about innocan pharma reports second quarter 2024 results with revenue growth of over 2 8x to 8 6 million was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Innocan Pharma Reports Second Quarter 2024 Results with Revenue Growth of over 2.8X to $8.6 Million )

Apple Storegoogle play

Last updated :

Also on site :



Latest News